Literature DB >> 31011810

Electrospun polycaprolactone/hydroxyapatite/ZnO nanofibers as potential biomaterials for bone tissue regeneration.

Ajinkya A Shitole1, Piyush W Raut1, Neeti Sharma2, Prabhanjan Giram3, Anand P Khandwekar4, Baijayantimala Garnaik3.   

Abstract

Fabricating a bioartificial bone graft possessing structural, mechanical and biological properties mimicking the real bone matrix is a major challenge in bone tissue engineering. Moreover, the developed materials are prone to microbial invasion leading to biomaterial centered infections which might limit their clinical translation. In the present study, biomimetic nanofibrous scaffolds of Poly ɛ-caprolactone (PCL)/nano-hydroxyapatite (nHA) were electrospun with 1wt%, 5wt%, 10wt%, 15wt% and 30wt% of zinc oxide (ZnO) nanoparticles in order to understand the optimal concentration range of (ZnO) nanoparticles balancing both biocompatibility and osteoregeneration. The developed nanofibrous scaffolds were successfully characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy dispersive X-ray analysis (EDAX), contact angle, fourier transform infrared spectroscopy (FTIR), wide-angle X-Ray diffraction (WAXD), brunaueremmett Teller (BET) surface area and tensile testing. Biocompatibility of the developed scaffolds at in vitro level was evaluated by culturing MG-63 cells and investigating the impact on cell viability, proliferation, protein adsorption, alkaline phosphatase (ALP) activity and biomineralization. The PCL/nHA scaffolds exhibited a 1.2-fold increase in cell viability and proliferation, while incorporation of ZnO nanoparticles to PCL/nHA imparted antimicrobial activity to the scaffolds with a progressive increase in the antimicrobial efficacy with increasing ZnO concentration. The results of cell viability were supported by ALP activity and mineralization assay, wherein, PCL/nHA/ZnO scaffolds showed higher ALP activity and better mineralization capacity as compared to pristine PCL. Although, the PCL/nHA/ZnO scaffolds with 10, 15 and 30wt% of ZnO particles exhibited superior antimicrobial efficacy against both gram-negative (E. coli) and gram-positive (S. aureus) bacteria, a significant decrease in the cell viability and mechanical properties was observed at higher concentrations of ZnO namely 15 and 30%. Amongst the various ZnO concentrations studied optimal cell viability, antimicrobial effect and mechanical strength were observed at 10wt.% ZnO concentration. Thus, the present study revealed that the biomimetic tri-component PCL/nHA/ZnO scaffolds with ZnO concentration range of ≤ 10% could be ideal for achieving optimal biocompatibility (cell proliferation, biomineralization, and antimicrobial capacity) and mechanical stability thus making it a promising biomaterial substrate for bone tissue regeneration.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31011810     DOI: 10.1007/s10856-019-6255-5

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  9 in total

1.  Electrospun Membrane Surface Modification by Sonocoating with HA and ZnO:Ag Nanoparticles-Characterization and Evaluation of Osteoblasts and Bacterial Cell Behavior In Vitro.

Authors:  Julia Higuchi; Katarzyna Klimek; Jacek Wojnarowicz; Agnieszka Opalińska; Agnieszka Chodara; Urszula Szałaj; Sylwia Dąbrowska; Damian Fudala; Grazyna Ginalska
Journal:  Cells       Date:  2022-05-08       Impact factor: 7.666

Review 2.  Ceramic Nanofiber Materials for Wound Healing and Bone Regeneration: A Brief Review.

Authors:  Déborah Dos Santos Gomes; Rayssa de Sousa Victor; Bianca Viana de Sousa; Gelmires de Araújo Neves; Lisiane Navarro de Lima Santana; Romualdo Rodrigues Menezes
Journal:  Materials (Basel)       Date:  2022-05-31       Impact factor: 3.748

3.  Development of titanium dioxide nanowire incorporated poly(vinylidene fluoride-trifluoroethylene) scaffolds for bone tissue engineering applications.

Authors:  Anitha Augustine; Robin Augustine; Anwarul Hasan; Varun Raghuveeran; Didier Rouxel; Nandakumar Kalarikkal; Sabu Thomas
Journal:  J Mater Sci Mater Med       Date:  2019-08-14       Impact factor: 3.896

4.  Characterization of Polycaprolactone Nanohydroxyapatite Composites with Tunable Degradability Suitable for Indirect Printing.

Authors:  Stephanie E Doyle; Lauren Henry; Ellen McGennisken; Carmine Onofrillo; Claudia Di Bella; Serena Duchi; Cathal D O'Connell; Elena Pirogova
Journal:  Polymers (Basel)       Date:  2021-01-18       Impact factor: 4.329

5.  Modeling Experimental Parameters for the Fabrication of Multifunctional Surfaces Composed of Electrospun PCL/ZnO-NPs Nanofibers.

Authors:  Pedro J Rivero; Juan P Fuertes; Adrián Vicente; Álvaro Mata; José F Palacio; María Monteserín; Rafael Rodríguez
Journal:  Polymers (Basel)       Date:  2021-12-09       Impact factor: 4.329

Review 6.  Nature-Derived and Synthetic Additives to poly(ɛ-Caprolactone) Nanofibrous Systems for Biomedicine; an Updated Overview.

Authors:  Shahin Homaeigohar; Aldo R Boccaccini
Journal:  Front Chem       Date:  2022-01-19       Impact factor: 5.221

Review 7.  Recent Advances in Hydroxyapatite-Based Biocomposites for Bone Tissue Regeneration in Orthopedics.

Authors:  Ileana Ielo; Giovanna Calabrese; Giovanna De Luca; Sabrina Conoci
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

Review 8.  Hydrogen Sulfide in Bone Tissue Regeneration and Repair: State of the Art and New Perspectives.

Authors:  Laura Gambari; Brunella Grigolo; Francesco Grassi
Journal:  Int J Mol Sci       Date:  2019-10-22       Impact factor: 5.923

9.  Three Component Composite Scaffolds Based on PCL, Hydroxyapatite, and L-Lysine Obtained in TIPS-SL: Bioactive Material for Bone Tissue Engineering.

Authors:  Aleksandra Korbut; Marcin Włodarczyk; Karolina Rudnicka; Aleksandra Szwed; Przemysław Płociński; Monika Biernat; Paulina Tymowicz-Grzyb; Martyna Michalska; Natalia Karska; Sylwia Rodziewicz-Motowidło; Konrad Szustakiewicz
Journal:  Int J Mol Sci       Date:  2021-12-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.